Skip to main content
Premium Trial:

Request an Annual Quote

Agilent OneSight Platform

Agilent Technologies has launched its OneSight, a new software platform designed to help researchers visualize and analyze chromosomal aneuploidies in cell-free DNA sequencing data. OneSight offers genetics laboratories a cost-effective way to perform high-quality, cell-free DNA analysis in-house, the company said. The software platform is independent of NGS sequencing technology and allows labs to set up an end-to-end cfDNA analysis pipeline. The new software was developed using expertise from Cartagenia, a company Agilent acquired last year that is known for its software solutions for variant assessment and reporting of clinical genomics data.  

The Scan

Omicron's Emergence

The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes.

Not as Much

Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says.

Bats That Hang Together

Discover magazine writes that researchers have found a social microbiome among vampire bats.

PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers

In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.